Cite
HARVARD Citation
Guardiola, J. et al. (n.d.). P635 Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to infliximab in patients with inflammatory bowel disease. Journal of Crohn's and colitis. pp. S435-S436. [Online].